Gold Or Silver Patents (Class 514/495)
  • Patent number: 7887749
    Abstract: A new, novel and useful disinfection and purification system comprised of organic compounds in synergistic action with selected metal ions and method of manufacture and use. One of the benefits that is derived from this system is the ability to quickly and easily treat a surface, fluid or medium for disinfection of bacteria, fungi, viruses, algae and protozoans, with a non-toxic, non-chlorinated mixture that effectively kills all such organisms in minutes or hours. The disinfection and purification system remains effective for long periods of time maintaining its disinfection capacity making it highly effective for stored or transported mediums such as potable drinking water. The disinfection and purification system may be incorporated with carbon block or membrane filters to disinfect filtered liquids such as water to render it potable.
    Type: Grant
    Filed: November 29, 2007
    Date of Patent: February 15, 2011
    Inventor: Bradley J. Eldred
  • Publication number: 20110014256
    Abstract: A long-lasting anti-microbial composition is provided, which includes one or more polymer or oligomer and a plurality of nanowires distributed therein, wherein the nanowires have an aspect ratio of more than 20 and the nanowires form a network-like structure. An anti-microbial film and spray including the composition are also provided.
    Type: Application
    Filed: April 5, 2010
    Publication date: January 20, 2011
    Inventors: Ling-Ko CHANG, Yu-Ming Wang, Kao-Der Chang, Wen-Hsien Sun, Ming-Jyh Chang
  • Publication number: 20110009484
    Abstract: A non-toxic environmentally friendly aqueous disinfectant is disclosed for specific use as prevention against contamination by potentially pathogenic bacteria and virus. The aqueous disinfectant is formulated by electrolytically generating silver ions in water in combination with a citric acid. The aqueous disinfectant may include a suitable alcohol and/or a detergent. The aqueous disinfectant has been shown to be very effective at eliminating standard indicator organisms such as staphylococcus aureus, salmonella cholerasuis and pseudomonas aeruginosa.
    Type: Application
    Filed: July 12, 2010
    Publication date: January 13, 2011
    Applicant: Pure Bioscience
    Inventors: Andrew B. Arata, Michael L. Krall
  • Publication number: 20100324135
    Abstract: A non-toxic environmentally friendly aqueous disinfectant is disclosed for specific use as prevention against contamination by potentially pathogenic bacteria and virus. The aqueous disinfectant is formulated by electrolytically generating silver ions in water in combination with a citric acid. The aqueous disinfectant may include a suitable alcohol and/or a detergent. The aqueous disinfectant has been shown to be very effective at eliminating standard indicator organisms such as staphylococcus aureus, salmonella cholerasuis and pseudomonas aeruginosa.
    Type: Application
    Filed: August 27, 2010
    Publication date: December 23, 2010
    Applicant: Pure Bioscience
    Inventor: Andrew B. ARATA
  • Publication number: 20100260676
    Abstract: A method of preparing multifunctionalized nanoparticles involves using a modular system of half-linkers to attach functional moieties that serve to deliver the nanoparticles to a desired target, exert an effect at the target, or track the nanoparticles within a cell or an animal. The modular chemistry of the half-linker system permits the custom design and synthesis of functionalized nanoparticles bearing multiple groups and therefore results in precise delivery to desired cell types and intracellular locations. The functionalized nanoparticles can be used to treat or diagnose a variety of medical conditions, including neoplastic diseases, infectious diseases, and chronic diseases.
    Type: Application
    Filed: February 11, 2008
    Publication date: October 14, 2010
    Applicant: NORTHEASTERN UNIVERSITY
    Inventors: Robert N. Hanson, Mansoor Amiji, Volkmar Weissig
  • Publication number: 20100255055
    Abstract: The present invention relates to a gold-plated stent and its preparation method. More specifically, it relates to a gold-plated stent that is coated with various chemical materials such as 2-aminoalkanethiol, epihalogenhydrin, and diamine compounds in a sequence and also oligonucleotide gold-plated stent, which is prepared by binding oligonucleotide, a biomaterial, to the gold-plated stent coated with said chemicals. The oligonucleotide gold-plated stent of the present invention has an advantages of raising the local concentration in injured parts and minimizing the toxicity overall the body, so it can be used for prevention of restenosis after angioplasty.
    Type: Application
    Filed: June 16, 2008
    Publication date: October 7, 2010
    Inventors: Han-Oh Park, Jae-Don Lee, Sam-Yong Lee, Eun-Jung Jung
  • Publication number: 20100247461
    Abstract: Disclosed are certain complexes of AFC compounds and binding agents. Such complexes are useful, among other things, in the treatment of inflammatory diseases or disorders.
    Type: Application
    Filed: January 20, 2010
    Publication date: September 30, 2010
    Applicant: Signum Biosciences, Inc.
    Inventors: Michael Voronkov, Jeffry B. Stock, Maxwell Stock, Seung-Yub Lee, Eduardo Perez, Joel S. Gordon
  • Patent number: 7803407
    Abstract: A non-toxic environmentally friendly aqueous disinfectant is disclosed for specific use as prevention against contamination by potentially pathogenic bacteria and virus. The aqueous disinfectant is formulated by electrolytically generating silver ions in water in combination with a citric acid. The aqueous disinfectant may include a suitable alcohol and/or a detergent. The aqueous disinfectant has been shown to be very effective at eliminating standard indicator organisms such as staphylococcus aureus, salmonella cholerasuis and pseudomonas aeruginosa.
    Type: Grant
    Filed: June 19, 2003
    Date of Patent: September 28, 2010
    Assignee: Pure Bioscience
    Inventor: Andrew B. Arata
  • Publication number: 20100187263
    Abstract: This invention relates to compositions containing lower (C1-C4) alcohol and a polymeric fluorosurfactant formulated for being dispensed as a foam product. More particularly, the invention relates to improved compositions formulated with polymeric fluorosurfactants with pendant perfluoroalkyl side chains of a fully fluorinated chain length of C1-C7. The compositions also relate to use for personal care, such as skin sanitizing and cleansing.
    Type: Application
    Filed: April 2, 2010
    Publication date: July 29, 2010
    Applicant: The Clorox Company
    Inventors: David Lestage, David R. Scheuing, Scott L. Cumberland, Grant Templin
  • Publication number: 20100189611
    Abstract: This invention relates to compositions containing lower (C1-C4) alcohol and a polymeric fluorosurfactant formulated for being dispensed as a foam product. More particularly, the invention relates to improved compositions formulated with polymeric fluorosurfactants with pendant perfluoroalkyl side chains of a fully fluorinated chain length of C1-C7. The compositions also relate to use for personal care, such as skin sanitizing and cleansing.
    Type: Application
    Filed: April 2, 2010
    Publication date: July 29, 2010
    Applicant: The Clorox Company
    Inventors: David Lestage, David R. Scheuing, Scott L. Cumberland, Grant Templin
  • Publication number: 20100189809
    Abstract: This invention relates to compositions containing lower (C1-C4) alcohol and a polymeric fluorosurfactant formulated for being dispensed as a foam product. More particularly, the invention relates to improved compositions formulated with polymeric fluorosurfactants with pendant perfluoroalkyl side chains of a fully fluorinated chain length of C1-C7. The compositions also relate to use for personal care, such as skin sanitizing and cleansing.
    Type: Application
    Filed: April 2, 2010
    Publication date: July 29, 2010
    Applicant: The Clorox Company
    Inventors: David Lestage, David R. Scheuing, Scott L. Cumberland, Grant Templin
  • Patent number: 7732485
    Abstract: The invention relates to the treatment of cancers, in particular, cancers that are resistant to platinum based chemotherapeutic agents. A pharmaceutical composition for the treatment of cancer comprising an effective amount of a compound having two gold(I) atoms each covalently bonded to a carbon atom in a covalent link connecting the two gold(I) atoms and a pharmaceutically acceptable excipient.
    Type: Grant
    Filed: December 20, 2004
    Date of Patent: June 8, 2010
    Assignee: The University of Manchester
    Inventors: Kevin Flower, Alan McGown
  • Publication number: 20100119608
    Abstract: Among natural mechanisms of cell deaths, disease or toxicity, one of the most common method is through overloading of certain biological metals such as calcium, iron and zinc. We propose to utilize this natural mechanism of cell death against cancer by utilizing the well known phenomenon of enhanced permeation and retention effect (EPR effect) and metal-binding nanoparticle moieties that can self-degrade under certain biological conditions such as pH. More specifically, we show that one can form nanoparticles that consist of polymerized citric acid and various different types of metals including, but not limited to, iron, calcium, zinc, silver and magnesium, displaying acid-stability and self-degradation leading to constituent metal release when pH rises closer to the neutral pH of 7 or higher.
    Type: Application
    Filed: November 11, 2008
    Publication date: May 13, 2010
    Inventor: Jinhyuk Fred Chung
  • Publication number: 20100099758
    Abstract: A composition containing copper and silver ions electrolytically generated in a solution of citric acid that also contains potassium carbonate is shown to expedite the healing of wounds with regeneration of normal tissue architecture and without excessive scarring. A wide range of wounds and other forms of tissue damage affecting the skin and other areas of the body respond favorably to the direct application of the composition, with expedited healing, re-growth of normal appearing (non-scar) tissue and symptomatic relief from pain and swelling. The composition acts in both humans and animals through a novel mechanism provisionally termed the tissue regeneration induced pathway (TRIP).
    Type: Application
    Filed: October 22, 2008
    Publication date: April 22, 2010
    Applicant: MI Hope Inc.
    Inventors: William John Martin, Stephen Benet Palmer
  • Publication number: 20100099759
    Abstract: A method for treating a plant, the method comprising contacting a composition comprising silver dihydrogen citrate with at least one of the plant, a portion of soil and/or groundwater proximal to the plant, or a combination thereof.
    Type: Application
    Filed: June 8, 2009
    Publication date: April 22, 2010
    Inventors: Michael L. KRALL, Andrew B. Arata
  • Patent number: 7700131
    Abstract: Powders having contact biocidal properties comprise a polysaccharide carrying atomic/metallic silver. The preferred polysaccharide is chitin, although other polysaccharides including chitosan, carboxymethyl celluloses and carrageenans can be used. The chitin may be obtained from deproteinated crustacean shells without demineralisation, thus being admixed with calcium carbonate and other naturally occurring minerals present in the shells, and may be enzyme deacetylated. The powders of the invention can be used as biocidal dusting powders, formulated into pastes, gels, hydrogels, creams, foams and aerosol sprays for pharmaceutical applications, or dissolved to form solutions for coating substrates such as skin, fabrics, glass, leather and paper to give a bactericidal surface. A particular application of such a solution is as a protective, post-wash treatment for workwear in a laundering process.
    Type: Grant
    Filed: July 18, 2005
    Date of Patent: April 20, 2010
    Assignee: Chitoproducts Limited
    Inventors: Alan Taylor, George Andrew Francis Roberts, Frances Ann Wood
  • Publication number: 20100093851
    Abstract: A polymer composite comprising a thermoplastic polyamide polymer compounded with an organo-disulfide additive and a silver-based antimicrobial agent is disclosed. The organo-disulfide additive inhibits undesirable discoloration of the thermoplastic polyamide polymer including one or more silver-based antimicrobial agent. Processes for preparing the composite are also disclosed, including compounding the organo-disulfide additive in a polymeric carrier with the silver-based antimicrobial agent, then with the thermoplastic polyamide polymer, or compounding the organo-disulfide additive with the thermoplastic polyamide polymer before adding the silver-based antimicrobial agent.
    Type: Application
    Filed: October 14, 2008
    Publication date: April 15, 2010
    Inventors: Thomas N. Blanton, David W. Sandford, Kevin L. Bishop
  • Publication number: 20100092530
    Abstract: Novel silver-triclosan salts are provided which have antimicrobial properties and may be used as pharmaceutical compositions or to treat articles such as medical devices, packaging materials, and textiles.
    Type: Application
    Filed: September 20, 2007
    Publication date: April 15, 2010
    Inventors: Joshua B. Stopek, Brian Cuevas, Nadya Belcheva
  • Publication number: 20100087522
    Abstract: A drug having a muscle relaxing effect can be prepared by binding negatively charged gold nanoparticles having a size of 1.4 nm fitted to synaptic clefts to choline through ionic bonds, thereby inducing gold-sulfur bonds in the Cys loop of an acetylcholine receptor in neuromuscular junction, and thus blocking the electric current induced in signal transduction from a nerve to a muscle, thereby blocking neuromuscular transmission chemically and physically. When the reverse is administered after surgery, the gold-sulfur bonds are broken due to the re-flow of the electric current, and thus the gold nanoparticles are again released and metabolized into neuromuscular junction. Further, such muscle relaxing effect can be applied as an anticonvulsant.
    Type: Application
    Filed: November 22, 2007
    Publication date: April 8, 2010
    Inventor: Chur Chin
  • Publication number: 20100086605
    Abstract: A coating product composition has the general formula AOx-(L-Men+)i, wherein AOx is a metal or metalloid oxide in which x indicates the number of the Oxygen atom(s) (O) bonded to the metal (A) atom, Men+ is a metal ion, L is a bifunctional molecule that could bind both metal oxide or metalloid oxide (AOx) and the metal ion (Men+), i is the number of the (L-Men+) groups bound to the metal oxide AOx. The value of the parameter i depends on various factors, such as the size of the nanoparticle of AOx, and the nature of the molecule L.
    Type: Application
    Filed: October 12, 2006
    Publication date: April 8, 2010
    Applicant: NM TECH NANOMATERIALS MICRODEVICE TECHNOLOGY LTD.
    Inventors: Carlo Alberto Bignozzi, Valeria Dissette
  • Patent number: 7687076
    Abstract: A method for producing a deposition product includes providing a deposition solution having a pH below 7 and comprising an aqueous solution of a silver salt comprised of silver ions and an oxidizing agent. The silver salt is comprised of silver nitrate and has a concentration in the deposition solution between about 1 and 20 grams per liter. The oxidizing agent is comprised of a persulfate and has a concentration in the deposition solution between about 1 and 50 grams per liter. The method further includes producing the deposition product by facilitating a chemical reaction between the silver ions and the oxidizing agent while maintaining the deposition solution at a temperature of between about 2 and 40 degrees Celsius. The deposition product consists essentially of at least one oxidized silver species, and is comprised of a compound having the formula Ag7O8X, where X is an anion.
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: March 30, 2010
    Assignee: Exciton Technologies Inc.
    Inventor: Stojan Djokic
  • Publication number: 20100074932
    Abstract: Antimicrobial compositions may provide varying release kinetics for the active ions in the compositions due to the different water solubilities of the ions, allowing antimicrobial release profiles to be tailored for a given application and providing for sustained antimicrobial activity over time. According to some embodiments, the antimicrobial compositions may comprise polymer compositions containing colloids including salts of one or more oligodynamic metals, such as gallium. The antimicrobial compositions may be produced, for example, by mixing a solution of the salts of one or more oligodynamic metals with a polymer solution or dispersion and precipitating a colloid of the metal salts by addition of other salts to the solution which react with the metal salts. The compositions can be incorporated into articles or can be employed as a coating on articles such as medical devices including, for example, catheters, implants, and endotracheal tubes. The coatings may be on all or part of a surface.
    Type: Application
    Filed: September 20, 2007
    Publication date: March 25, 2010
    Inventor: Silke Talsma
  • Publication number: 20100056485
    Abstract: Disclosed herein is a silver nanoparticle based antimicrobial composition and methods for making the same. The antimicrobial composition comprises an amphiphilic molecule having at least one hydrophilic group and at least hydrophobic groups attached thereto; and an at least one silver nanoparticle in contact with the amphiphilic molecule. Also disclosed are uses for the antimicrobial composition such as for the treatment of skin disorders.
    Type: Application
    Filed: August 28, 2008
    Publication date: March 4, 2010
    Inventor: Seung Bum Park
  • Publication number: 20100047312
    Abstract: The invention relates to a stent having a coating or cavity filling comprising or containing an organic Au complex.
    Type: Application
    Filed: August 13, 2009
    Publication date: February 25, 2010
    Inventor: Eric Wittchow
  • Patent number: 7655810
    Abstract: A phosphine transition metal complex is expressed by general formula (1): wherein A represents a groups selected from among alkylene, phenylene, and cis-vinylene; M represents an atom selected from the group consisting of gold, silver, copper, and platinum; B1 and B2 each represent a substituted or unsubstituted heterocyclic group containing a trivalent phosphorus atom forming a covalent bond with A and coordinating with M; and C represents an anionic atom.
    Type: Grant
    Filed: November 30, 2006
    Date of Patent: February 2, 2010
    Assignee: Nippon Chemical Industrial Co., Ltd.
    Inventors: Hiroaki Kodama, Keisuke Ohto, Nobuhiko Oohara, Kazuhiro Nakatsui, Yoshirou Kaneda
  • Patent number: 7641912
    Abstract: Antimicrobial coatings to protect surfaces and a method of applying such a coating are disclosed. An antimicrobial coating may be applied to a surface, such as the interior surface of a building's exterior wall. The interior surface must be accessed, and then an antimicrobial coating is provided and applied. The antimicrobial coating includes an inorganic antimicrobial additive and a colloidal polymeric medium. The inorganic antimicrobial additive may be silver, platinum, gold, palladium, copper, zinc, boron, or a compound of any of those elements. By including an ultraviolet tracer or color dye additive in the coating, it is possible to detect the coating at any time, provided that the surface is accessed.
    Type: Grant
    Filed: January 12, 2004
    Date of Patent: January 5, 2010
    Assignee: EnviroCare Corporation
    Inventor: Bryan M. Redler
  • Publication number: 20090324738
    Abstract: Methods for forming antimicrobial coatings on substrate surfaces are disclosed. The methods involve providing a mixture comprising a metal salt, a biguanide compound, and a reducing agent, wherein the mixture is free of polymeric binders; and depositing the mixture onto a substrate surface, thereby forming a coated substrate surface.
    Type: Application
    Filed: June 30, 2008
    Publication date: December 31, 2009
    Applicants: BAXTER INTERNATIONAL INC., BAXTER HEALTHCARE S.A.
    Inventor: VADIM V. KRONGAUZ
  • Patent number: 7601755
    Abstract: A process is disclosed for treating impure water by introducing a solution of electrolyticially generated silver citrate into the impure water wherein the silver is electrolytically generated in a solution of citric acid and water.
    Type: Grant
    Filed: May 9, 2005
    Date of Patent: October 13, 2009
    Assignee: Pure Bioscience
    Inventor: Andrew B. Arata
  • Patent number: 7585460
    Abstract: The invention relates to a method for inhibiting the biological acidification of water which is in contact with materials containing sulfur in reduced form or with elemental sulfur, susceptible to oxidation on the part of Thiobacilli, comprising putting said materials in contact with soluble inorganic salts at concentrations ranging from 0.4 normal to saturation.
    Type: Grant
    Filed: April 26, 2004
    Date of Patent: September 8, 2009
    Assignees: ENI S.p.A., Enitecnologie S.p.A.
    Inventors: Francesco Crescenzi, Antonella Crisari, Cesare Achille Piatti
  • Publication number: 20090186064
    Abstract: This invention provides a modified catheter biomaterial that provides both immediate, and long-term microbiocidal effects on otherwise antibiotic-resistant strains of microorganisms. The material, which exhibits good mechanical performance characteristics for medical devices, is composed of a hydrophobic polyurethane (PU), a hydrophilic polyethylene vinyl acetate (PEVA), a soluble silver salt and a sparsely-soluble silver salt. The hydrophobic polyurethane provides the good physical properties, the PEVA the hydrophilicity necessary to allow some water ingress into the catheter, the soluble silver salt for an immediate burst effect, and the sparsely-soluble silver salt for sustained-release over many months postimplantation.
    Type: Application
    Filed: December 31, 2008
    Publication date: July 23, 2009
    Inventor: Michael Szycher
  • Patent number: 7563818
    Abstract: The present invention relates to self-assembly of a photosensitizer on a nanoparticle. The invention also provides methods for production of functionalized (eg. stabilized) nanoparticles. The nanoparticles may be used in Photodynamic Therapy (PDT). The invention can provide, for example, self-assembled phthalocyanine monolayers (SAMs), wherein the monolayer is formed on a metallic nanoparticle. The term “metallic” as used herein refers to metals, metal oxides and other metal-containing compositions. According to the invention a functionalized nanoparticle comprises: a metallic core; a photosensitizer monolayer chemically bonded to said core, said monolayer containing molecules capable of photo-excitation to produce a reactive oxygen species such as singlet oxygen, from oxygen molecules; and a phase transfer reagent.
    Type: Grant
    Filed: October 31, 2002
    Date of Patent: July 21, 2009
    Assignee: Cancer Research Technology Limited
    Inventors: David Andrew Russell, Duncan Christopher Hone
  • Publication number: 20090176875
    Abstract: A method for manufacturing a stabilized metal nano particle solution is disclosed. This method manufactures a metal nano particle solution so as to make a metal substance such as silver, gold, copper, zinc or cobalt into ultra-capsular nano particles. That is to say, this new method is simple and suitable for mass production without requiring any separate reducer putting process at a room temperature while a transition metal nano particle solution is produced. In this method, an alcohol solution including a metal salt solution and a soluble polymer is mixed at a room temperature to make a nano metal particle solution with a particle size of 100 nm or less.
    Type: Application
    Filed: January 9, 2008
    Publication date: July 9, 2009
    Inventors: Dong-Pyo Kim, Yoon-Hyuck Choi, Choong G. Row
  • Publication number: 20090176876
    Abstract: Compositions, kits and regimens for treatment of damaged skin, especially décolletage, include application of a retinoid, hydroquinone or hydroquinone derivatives, and a composition containing a multi-metal complex.
    Type: Application
    Filed: December 10, 2008
    Publication date: July 9, 2009
    Applicant: JR CHEM, LLC
    Inventors: Jose E. Ramirez, Joseph R. Faryniarz
  • Publication number: 20090131517
    Abstract: A flame spray pyrolysis method for producing a doped silica(SiO2) having antimicrobial and/or antibacterial and/or antifungal effect and being in the form of particles is disclosed. Said flame made doped silica comprises at least one functional dopant consisting of at least one antimicrobial and/or antibacterial and/or antifungal acting metal and/or metal-oxide, and is produced starting from a precursor solution comprising at least one functional dopant precursor, in particular a silver and/or copper comprising precursor, and at least one silica precursor in an organic solvent. Such doped silica is suitable for being incorporated within e.g. polymeric materials or for being used as impregnating material.
    Type: Application
    Filed: February 9, 2006
    Publication date: May 21, 2009
    Inventors: Murray Height, Sotiris E. Pratsinis
  • Publication number: 20090123513
    Abstract: A compound comprising a metal species and a biologically acceptable ligand, wherein the biologically acceptable ligand comprises a biguanide moiety, and wherein the biologically acceptable ligand forms a complex with the metal species in which the metal species is stabilised in an oxidation state greater than 1+. Compositions and medical devices comprising the compound. A method for the treatment or prophylaxis of microbial, including bacterial, infections, comprising the use of such compounds, compositions or medical devices.
    Type: Application
    Filed: June 27, 2006
    Publication date: May 14, 2009
    Inventor: Bryan Greener
  • Publication number: 20090099257
    Abstract: A composition and process is disclosed for treating an acne infection with a composition of electrolytically generated silver citrate. The composition of electrolytically generated silver citrate may be applied topically to the acne infection in an aqueous solution or may be incorporated within a cosmetic product. The acne composition may be combined with a composition component such as a cosmetic, a lotion, an emulsion, a gel or a soap.
    Type: Application
    Filed: December 19, 2008
    Publication date: April 16, 2009
    Inventor: Andrew B. Arata
  • Publication number: 20090098226
    Abstract: Composition in the form of a cosmetic formulation or dermatological medicament, suitable for maintaining skin cells at, or helping to restore skin cells to, their basal physiological state, enabling them to effect a regeneration of the dermis and the epidermis, comprising: —curcumin—a phosphosaccharide and possibly—a metal or basic oxide, or a biologically acceptable salt thereof, or a labile coordination compound thereof able to form, with at least one of said compounds: complexes, derivatives or associations which enhance their activity, in combination with excipients and/or diluents normally employed for cosmetic or pharmaceutical use.
    Type: Application
    Filed: March 13, 2007
    Publication date: April 16, 2009
    Applicant: SCHARPER S.P.A.
    Inventors: Laura Martelli, Mario Martelli
  • Publication number: 20090061021
    Abstract: The present invention relates to combinations of imazalil, or a salt thereof, and silver compounds which provide an improved biocidal effect. More particularly, the present invention relates to compositions comprising a combination of imazalil, or a salt thereof, together with one or more silver salts selected from silver acetate, silver alginate, silver azide, silver citrate, silver lactate, silver nitrate, silver sulfate, silver chloride, silver thiocyanate, silver-sodium-hydrogen-zirconium phosphate, silver sulfadiazine, silver cyclohexanediacetic acid and disilver 2,5-dichloro-3,6-dihydroxy-2,5-cyclohexadiene-1,4-dione; in respective proportions to provide a synergistic biocidal effect.
    Type: Application
    Filed: March 6, 2005
    Publication date: March 5, 2009
    Inventors: Amber Paula Marcella Thys, Jan Pieter Hendrik Bosselaers, Dany Leopold Jozefien Bylemans
  • Publication number: 20090035342
    Abstract: The present invention comprises methods and compositions for antimicrobial devices comprising metal containing compositions which are resistant to heat and light discoloration. The metal containing compositions may comprise salts or complexes of silver, copper or zinc. In one aspect the compositions comprise silver salts. In another aspect, the compositions comprise silver complexes. In one aspect, the metal salts may comprise metal salts of saccharin, acesulfame, long chain fatty acids, and alkyl dicarboxylic acids. The compositions further comprise polymers which form salts or complexes with silver, copper or zinc. The methods of the present invention comprise treating devices with the metal containing compositions, including, but not limited to, such devices as woven wound care materials, catheters, patient care devices, and collagen matrices. The present invention further comprises treatment of humans and animals with the antimicrobial devices described herein.
    Type: Application
    Filed: August 1, 2005
    Publication date: February 5, 2009
    Inventors: Bhalchandra M. Karandikar, Bruce L. Gibbins, Ken A. Cornell
  • Publication number: 20090035388
    Abstract: The invention is an antimicrobial photo-stable coating composition that deters photo-induced discoloration, does not stain tissue and can be applied to the surface of a variety of medical materials. The composition comprises in an aspect silver-PCA complex and dye.
    Type: Application
    Filed: July 31, 2008
    Publication date: February 5, 2009
    Inventors: Vyacheslav Dudnik, Yakeemovich Natali, Valerio DiTizio, Frank DiCosmo
  • Patent number: 7485259
    Abstract: A new, novel and useful disinfection and purification system comprised of organic compounds in synergistic action with selected metal ions and method of manufacture and use. One of the benefits that is derived from this system is the ability to quickly and easily treat a surface, fluid or medium for disinfection of bacteria, fungi, viruses, algae and protozoans, with a non-toxic, non-chlorinated mixture that effectively kills all such organisms in minutes or hours. The disinfection and purification system remains effective for long periods of time maintaining its disinfection capacity making it highly effective for stored or transported mediums such as potable drinking water. The disinfection and purification system may be incorporated with carbon block or membrane filters to disinfect filtered liquids such as water to render it potable.
    Type: Grant
    Filed: October 6, 2003
    Date of Patent: February 3, 2009
    Inventor: Bradley J. Eldred
  • Publication number: 20090018188
    Abstract: Disclosed are surfactant compounds and compositions that are antimicrobial. Also provided are polymeric compositions incorporating the surfactant compounds. The polymeric compositions may be used to form antibacterial coatings on surfaces.
    Type: Application
    Filed: July 9, 2008
    Publication date: January 15, 2009
    Inventor: John Texter
  • Patent number: 7470437
    Abstract: Methods of treating conditions with a metal-containing material are disclosed. The metal-containing material can be, for example, an antimicrobial material, an antibacterial material, an anti-inflammatory material, an anti-fungal material, an anti-viral material, an anti-cancer material, a pro-apoptosis material, and/or an MMP modulating material. In certain embodiments, the metal-containing material is an atomically disordered, silver-containing material.
    Type: Grant
    Filed: November 10, 2004
    Date of Patent: December 30, 2008
    Assignee: Nucryst Pharmaceuticals Corp.
    Inventors: Robert E. Burrell, John B. Wright, Kan Lam, Antony G. Naylor, Peter H. Moxham, Scott H. Gillis, Paul Schechter
  • Publication number: 20080319062
    Abstract: A non-toxic environmentally friendly aqueous disinfectant is disclosed for specific use as prevention against contamination by potentially pathogenic bacteria, fungi and virus. The aqueous disinfectant is formulated by electrolytically generating silver ions in water in combination with a citric acid. The aqueous disinfectant has many potential uses including bacteria, fungus and viral treatment, water treatment, medical treatment as well as for preserving consumable and non-consumable products.
    Type: Application
    Filed: September 4, 2008
    Publication date: December 25, 2008
    Inventor: Andrew B. Arata
  • Publication number: 20080292674
    Abstract: Bioactive agrichemical concentrates and compositions having improved bioactivity comprising combinations of acid solutions and conventional bioactive agrichemical actives or formulations.
    Type: Application
    Filed: May 19, 2008
    Publication date: November 27, 2008
    Inventor: Joseph J. Crudden
  • Publication number: 20080292673
    Abstract: Bioactive agrichemical concentrates and compositions having improved bioactivity comprising combinations of acid solutions and conventional bioactive agrichemical actives or formulations.
    Type: Application
    Filed: May 19, 2008
    Publication date: November 27, 2008
    Inventor: Joseph J. Crudden
  • Patent number: 7445799
    Abstract: An antimicrobial and chemical deactivating composition for use in a liquid medium or for incorporation into a coating, structural plastic materials, thin microporous membranes, textiles and sponges. The composition includes macrosize or submicron particles of silver, platinum with silver and their salts with parabens, oxide, salicylate, acetate, citrate, benzoate and phosphate along with copper and zinc salts of the same.
    Type: Grant
    Filed: June 21, 2001
    Date of Patent: November 4, 2008
    Assignee: ICET, Inc.
    Inventors: Shantha Sarangapani, Quoc T. Truong
  • Patent number: 7435438
    Abstract: A process is disclosed for treating consumable food products, the process comprising the step of applying to a consumable food product an aqueous disinfectant solution comprising silver dihydrogen citrate in an amount sufficient to obtain at least a 2.36 log10 reduction in the number of microorganisms present. Also disclosed is a process comprising applying to a consumable food product an aqueous disinfectant solution comprising from 5 ppm to 30 ppm of silver dihydrogen citrate and from 5% to 10% citric acid. Also disclosed is a process comprising exposing a consumable food product to from 5 ppm to 30 ppm of silver dihydrogen citrate for at least 5 seconds, allowing the food product to drip dry, and rinsing the food product with at least 0.1 ppm of silver dihydrogen citrate.
    Type: Grant
    Filed: February 16, 2005
    Date of Patent: October 14, 2008
    Assignee: Pure BioScience
    Inventor: Andrew B. Arata
  • Patent number: 7427416
    Abstract: Methods of treating conditions using metal-containing materials are disclosed. Exemplary conditions include bacterial conditions, biofilm conditions, microbial conditions, inflammatory conditions, fungal conditions, viral conditions, autoimmune conditions, idiopathic conditions, hyperproliferative conditions, noncancerous growths, cancerous conditions and combinations of such conditions. In certain embodiments, the metal-containing material is an atomically disordered, nanocrystalline silver-containing material.
    Type: Grant
    Filed: October 22, 2003
    Date of Patent: September 23, 2008
    Assignee: Nucryst Pharmaceuticals Corp.
    Inventors: Scott H. Gillis, Paul Schechter, James Alexander Robert Stiles
  • Publication number: 20080215122
    Abstract: The present invention provides for a method to increase the triplet yield of a photosensitizer by the coupling to metal surface plasmons which leads to increased singlet oxygen generation by electric field enhancement or enhanced energy absorption of the photosensitizer. The extent of singlet oxygen enhancement can be tuned for applications in singlet oxygen based clinical therapy by modifying plasmon coupling parameters, such as metallic nanoparticle size and shape, photosensitizer/metallic nanoparticle distance, and the excitation wavelength of the coupling photosensitizer.
    Type: Application
    Filed: January 27, 2008
    Publication date: September 4, 2008
    Inventor: Chris D. Geddes